Article
Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.
Breast cancer research and treatment - 1 Feb 2017
Ma Ding, Jiang Yi-Zhou, Liu Xi-Yu, Liu Yi-Rong, Shao Zhi-Ming
Abstract excerpt
PURPOSE: Intra-tumor heterogeneity (ITH) plays a pivotal role in driving breast cancer progression and therapeutic resistance. We used a mutant-allele tumor heterogeneity (MATH) algorithm to measure ITH and explored its correlation with clinical parameters and multi-omics data. METHODS: We assessed 916 female breast cancer patients from The Cancer Genome Atlas. We calculated the MATH values from whole-exome...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
